Delivery Order SPE2DB24D3015-SPE2DB25FFXEA

Award Date 11/27/24
Potential Completion Date 11/29/24
Potential Value $3.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Forteo 560 mcg/2.24 ml pen injections. The contract has a ceiling value of $12,869.67 and is a firm fixed-price, non-set-aside award with a performance period through May 2025. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which serves as a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $5,048.61, is for the supply of Forteo 600 mcg/2.4 ml pen injections. The award is not part of a set-aside program. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of Forteo 600 mcg/2.4 ml pen injection medication. The contract has a ceiling value of $18,657.29 and a completion date of November 4, 2024. The contract is a firm fixed-price delivery order and does not have a set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Forteo 600 MCG/2.4 ML pen injections. The contract has a ceiling value of $4,725.07 and an ultimate completion date of March 8, 2023. The contract is a firm fixed price delivery order, with no set-aside designation, indicating the award was made through full and open competition. AmerisourceBergen Drug Corp is a subsidiary of Cencora,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Forteo 600 mcg/2.4 ml pen injections. The contract has a firm fixed price of $10,589.55 and a completion date of November 8, 2024. It is not designated as a set-aside contract. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract is for the delivery of Forteo 600 mcg/2.4 ml pen injection medication, with a potential value of $10,207.95 and a completion date of February 21, 2024. Amerisourcebergen Drug Corp serves as the prime contractor on this order, which is part of a...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $20,742.59, is for the delivery of Forteo 600 mcg/2.4 ml pen injections. The contract is a firm fixed-price delivery order with a completion date of February 27, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the pharmaceutical product Forteo (teriparatide) 560 mcg/2.24 mL pen injector, with a ceiling value of $24,574.40 and a period of performance through June 2, 2025. The contract is a firm fixed-price, non-set-aside agreement to provide this medication to the DLA, which supports...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $6,768.31 contract is for the supply of Forteo 600 mcg/2.4 ml pen injections, with a performance period through April 5, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA Troop Support Medical, valued at up to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Forteo 600 mcg/2.4 ml pen injectors. The delivery order has a ceiling value of $44,165.74 and a period of performance through March 27, 2025. It is a firm fixed price contract with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is the prime contractor for this award, which is likely part of a larger...
  • SPE2DB24D3015
    Indefinite Delivery Contract
  • SPE2DB24D3015-SPE2DB25FFXEA
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Forteo 600 mcg/2.4 ml pen injections. The contract has a ceiling value of $3,252.95 and a period of performance through November 29, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds an Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order is not designated with a set-aside requirement, indicating open competition. The contract award demonstrates DLA's pharmaceutical and medical supply procurement from AmerisourceBergen to meet the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 2/26/25, 9:43 AM